1-3 of 3
Jonas Nilsson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B08: Tumor-educated platelets for early prostate cancer diagnosis, and therapy stratification in patients with metastasized castration resistant prostate cancer

Lee-Ann Tjon-Kon-Fat, Linda Köhn, Myron Best, Marie Lundholm, Thomas Wurdinger, Anders Widmark, Camilla Thellenberg-Karlsson, Pernilla Wikström, Jonas Nilsson
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11_Supplement): B08.
https://doi.org/10.1158/1557-3265.LiqBiop20-B08
Published: 01 June 2020
View article titled, Abstract B08: Tumor-educated platelets for early prostate cancer diagnosis, and therapy stratification in patients with metastasized castration resistant prostate cancer
Journal Articles

Abstract B30: Regulation of angiogenesis by the VEGF/miR-101/EZH2 axis

Michiel Smits, Shahryar E. Mir, Jonas Nilsson, Petra van der Stoop, Anneke Niers, Victor Marquez, Jacqueline Cloos, Xandra Breakefield, Anna Krichevsky, David Noske, Bakhos Tannous, Thomas Wurdinger
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7_Supplement): B30.
https://doi.org/10.1158/1078-0432.TCME10-B30
Published: 02 February 2016
View article titled, Abstract B30: Regulation of angiogenesis by the VEGF/miR-101/EZH2 axis
Journal Articles

Basoluminal Carcinoma: A New Biologically and Prognostically Distinct Entity Between Basal and Luminal Breast Cancer

Mervi Laakso, Minna Tanner, Jonas Nilsson, Tom Wiklund, Björn Erikstein, Pirkko Kellokumpu-Lehtinen, Per Malmström, Nils Wilking, Jonas Bergh, Jorma Isola
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (14): 4185–4191.
https://doi.org/10.1158/1078-0432.CCR-06-0353
Published: 20 July 2006
View article titled, Basoluminal Carcinoma: A New Biologically and Prognostically Distinct Entity Between Basal and Luminal Breast Cancer
Open the PDF for Basoluminal Carcinoma: A New Biologically and Prognostically Distinct Entity Between Basal and Luminal Breast Cancer in another window